RHINOCYTE Trademark

Trademark Overview

On Thursday, November 21, 2013, a trademark application was filed for RHINOCYTE with the United States Patent and Trademark Office. The USPTO has given the RHINOCYTE trademark a serial number of 86125153. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 16, 2017. This trademark is owned by RhinoCyte, Inc.. The RHINOCYTE trademark is filed in the Pharmaceutical Products category with the following description:

Human adult olfactory-derived stem cells for medical purposes for the therapeutic repair of neurotrama and neurodegenerative conditions as well as medical diagnostic purposes
rhinocyte

General Information

Serial Number86125153
Word MarkRHINOCYTE
Filing DateThursday, November 21, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 16, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 21, 2014

Trademark Statements

Goods and ServicesHuman adult olfactory-derived stem cells for medical purposes for the therapeutic repair of neurotrama and neurodegenerative conditions as well as medical diagnostic purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 2, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRhinoCyte, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLouisville, KY 402021209
Party NameRhinoCyte, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLouisville, KY 402021209

Trademark Events

Event DateEvent Description
Tuesday, January 17, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 16, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 5, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, July 3, 2016EXTENSION 3 GRANTED
Wednesday, June 15, 2016EXTENSION 3 FILED
Wednesday, June 15, 2016TEAS EXTENSION RECEIVED
Saturday, January 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 29, 2016EXTENSION 2 GRANTED
Tuesday, December 15, 2015EXTENSION 2 FILED
Thursday, January 28, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 15, 2015TEAS EXTENSION RECEIVED
Tuesday, May 12, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, May 9, 2015EXTENSION 1 GRANTED
Thursday, April 2, 2015EXTENSION 1 FILED
Saturday, May 9, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 2, 2015TEAS EXTENSION RECEIVED
Tuesday, December 16, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 21, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 21, 2014PUBLISHED FOR OPPOSITION
Wednesday, October 1, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 17, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 15, 2014ASSIGNED TO LIE
Tuesday, September 2, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 2, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 2, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 2, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 7, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 7, 2014NON-FINAL ACTION E-MAILED
Friday, March 7, 2014NON-FINAL ACTION WRITTEN
Friday, March 7, 2014ASSIGNED TO EXAMINER
Thursday, December 5, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 25, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

rhinocyte medical purposes neurodegenerative neurotrama conditions well diagnostic repair therapeutic stem